Global Malaria Vaccines Market Projected to Expand at 34.1% CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Malaria Vaccines Market Expected To Become By 2029 Compared With Its 2025 Level?

The size of the malaria vaccines market has seen substantial growth recently. This market is projected to expand from $4.7 billion in 2024 to reach $6.24 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 32.7%. Historically, this expansion has been driven by factors such as a significant malaria burden, worldwide health initiatives, available funding and grants, established malaria control programs, and robust government support alongside regulatory frameworks.

The malaria vaccines market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to “$20.19 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 34.1%.” This expansion during the forecast period can be attributed to global elimination objectives, broadened access programs, increasing vaccine coverage, international vaccine alliances, and the influence of climate change. Noteworthy trends for the forecast duration encompass technological innovations, public-private collaborations, global partnerships, and advancements in vaccine technology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13698&type=smp

Which Drivers Are Impacting The Malaria Vaccines Market?

The increasing occurrence of mosquito-related diseases is anticipated to drive the future expansion of the malaria vaccine market. These illnesses constitute a broad category of conditions transmitted through the bite of an infected mosquito. The malaria vaccine, particularly the RTS, S/AS01 (RTS, S) vaccine, operates by training the immune system to identify and attack the parasite, thereby preventing and reducing the impact of these mosquito-borne infectious diseases. For example, a report from the World Health Organization, a Switzerland-based intergovernmental organization, published in November 2023, estimated 249 million cases of malaria globally in 2022, which was an increase of 5 million cases from 2021. Additionally, Pakistan reported an estimated 2.6 million cases in 2022, a significant rise from the 500,000 cases recorded in 2021. Thus, the escalating incidence of mosquito-related diseases is a key factor boosting the growth of the malaria vaccine market.

Which Key Segments Fueling The Malaria Vaccines Market?

The malaria vaccinesmarket covered in this report is segmented –

1) By Agent: Plasmodium Falciparum; Plasmodium Vivax; Anopheles Species

2) By Vaccine Type: Pre-Erythrocytic; Erythrocytic; Multi-antigen; Other Vaccines

3) By Route Of Administration: Intramuscular; Subcutaneous; Intradermal; Other Routes

4) By Distribution Channel: Public; Private

Subsegments:

1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine; Other Experimental Vaccines

2) By Plasmodium Vivax: Candidate Vaccines In Development; Combination Vaccines

3) By Anopheles Species: Transmission-Blocking Vaccines; Vector Control Approaches

Which Competitive Trends Are Defining The Malaria Vaccines Market Structure?

Leading companies in the malaria vaccine market are actively developing innovative solutions, such as vaccines specifically for children’s malaria, to expand their customer base, boost sales, and increase revenue. Vaccines for mosquito-borne diseases are immunological formulations designed to offer protection against illnesses spread by mosquitoes. This particular pediatric vaccine targets Plasmodium falciparum, recognized globally as the deadliest malaria parasite and the most widespread in Africa. For instance, in November 2022, Malawi, an East African country, in collaboration with the World Health Organization, a Switzerland-based intergovernmental body, launched Africa’s first children’s malaria vaccine. A distinctive attribute of the RTSS vaccine, intended for young children, is its potential to lower mortality rates from this mosquito-transmitted disease. After undergoing pilot testing on over one million children in Ghana, Kenya, and Malawi, the vaccine, despite a modest 30% effectiveness rate, has generated optimism that it could save lives among the 400,000 individuals who succumb to malaria each year.

Who Are The Key Multinational Companies Dominating The Malaria Vaccines Market?

Major companies operating in the malaria vaccines market report are Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, Genvec Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

How Do Regional Market Performances Compare Within The Malaria Vaccines Industry?

North America was the largest region in the malaria vaccines market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Malaria Vaccines Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13698&type=smp

Browse Through More Reports Similar to the Global Malaria Vaccines Market 2025, By The Business Research Company

Inactivated Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Dog Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795